Yahoo Poland Wyszukiwanie w Internecie

Search results

1. www.ncbi.nlm.nih.gov › books › NBK577134Rheumatoid arthritis in adults: diagnosis and management

   www.ncbi.nlm.nih.gov › books › NBK577134

   2.3.4.1 Intervention reviews. The evidence for outcomes from the included RCTs and, where appropriate, non-randomised intervention studies, were evaluated and presented using an adaptation of the GRADE toolbox developed by the international GRADE working group (http://www.gradeworkinggroup.org/).

2. www.researchgate.net › publication › 377428188_Comprehensive_Review_Of_Rheumatoid(PDF) Comprehensive Review Of Rheumatoid Arthritis: Insights ...

   www.researchgate.net › publication › 377428188_Comprehensive_Review_Of_Rheumatoid

   10 sty 2024 · This comprehensive review explores the multifaceted landscape of rheumatoid arthritis (RA), encompassing its epidemiology, pathophysiology, clinical manifestations, diagnosis, treatment...

3. acrjournals.onlinelibrary.wiley.com › doi › pdfdirect2021 American College of Rheumatology Guideline for the Treatment...

   acrjournals.onlinelibrary.wiley.com › doi › pdfdirect

   The current recom-mendations address treatment with the following: 1) conventional synthetic disease- modifying antirheumatic drugs (csDMARDs), biologic DMARDs (bDMARDs), and targeted synthetic DMARDs (tsDMARDs); 2) glucocorticoids; and 3) use of these medications in certain high- risk populations.

4. www.researchgate.net › publication › 377182479_A_Comprehensive_Review_of_Treatment(PDF) A Comprehensive Review of Treatment Approaches and...

   www.researchgate.net › publication › 377182479_A_Comprehensive_Review_of_Treatment

   5 sty 2024 · Modern treatment options include methotrexate, hydrochloroquine, and more recent drugs like leflunomide and biologics like interleukin inhibitors and tumor necrosis factor (TNF) inhibitors,...

5. www.bmj.com › content › bmjTherapeutic advances in rheumatoid arthritis - The BMJ

   www.bmj.com › content › bmj

   Disease remission was rare. Two parallel developments of recent decades underlie advances in rheumatoid arthritis treatment. Firstly, an expanding armamentarium of targeted treatments has been driven by improved knowledge of the disease’s pathobiology, coupled with biotechnology developments.

6. link.springer.com › content › pdfRheumatoid arthritis: advances in treatment strategies - Springer

   link.springer.com › content › pdf

   The overall aim for treating RA is to achieve disease remis-sion. Although Methotrexate is a staple drug for its treatment, the repertoire of therapeutic options for rheumatologists has increased over the past decade.

7. link.springer.com › content › pdfTherapeutic Options and Cost-Effectiveness for Rheumatoid...

   link.springer.com › content › pdf

   rheumatic drugs (DMARDs) in combination with biologic (b) or targeted synthetic (ts) DMARDs has revolutionized RA treatment. Methotrexate administration is considered fundamental among other csDMARDs for the treatment of RA.